Radiopharmaceuticals : progress and clinical perspectives /

Radiopharmaceuticals : progress and clinical perspectives /

42

Opis bibliograficzny
1. autor:	Fritzberg, Alan R.
Format:
Wydane:	Boca Raton, Fla. : CRC Pr, 1986
Hasła przedmiotowe:	Radiopharmaceuticals

Podobne zapisy

Radiopharmaceuticals for positron emission tomography /
od: Scott, Peter J. H., i wsp.
Wydane: (c201)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
od: Welch, Michael J.
Wydane: (1977)

Radiopharmaceutical extravasations: a twenty year mini-review
od: Dustin R. Osborne
Wydane: (2023-07-01)

Radiopharmaceuticals from generator-produced radionuclides
od: International Atomic Energy Agency
Wydane: (1971)

Adverse reactions to radiopharmaceuticals
od: María del Val Gómez-Martínez, i wsp.
Wydane: (2021-05-01)

Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
od: Mengyi CHEN, i wsp.
Wydane: (2024-12-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
od: D. V. Goryachev, i wsp.
Wydane: (2025-02-01)

Regulation of Radiopharmaceutical Products
od: V. V. Kosenko, i wsp.
Wydane: (2022-12-01)

Pharmacokinetic Studies of Radiopharmaceuticals
od: A. S. Lunev, i wsp.
Wydane: (2022-12-01)

TO THE QUESTION OF RADIATION PROTECTION ENSURING OF PASSENGERS TAKEN RADIOPHARMACEUTICALS DURING TRANSPORTATION BY RAILWAY TRANSPORT
od: N. N. Artemyeva, i wsp.
Wydane: (2015-08-01)

Analytical and chromatographic technigues in radiopharmaceutical chemistry /
od: Wieland, Donald M., i wsp.
Wydane: (1986)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
od: Nicolas Lepareur, i wsp.
Wydane: (2025-02-01)

Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions
od: Sara Calistri, i wsp.
Wydane: (2024-10-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
od: G. E. Kodina, i wsp.
Wydane: (2022-10-01)

The main issues of quality assurance of radiopharmaceuticals
od: G. E. Kodina, i wsp.
Wydane: (2019-12-01)

Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
od: A. O. Malysheva, i wsp.
Wydane: (2022-11-01)

QUALITY CONTROL OF RADIOPHARMACEUTICALS IN MEDICAL INSTITUTIONS
od: G. E. Kodina, i wsp.
Wydane: (2019-01-01)

RADIOPHARMACEUTICALS BASED ON THE GLUCOSE DERIVATIVES FOR TUMOR DIAGNOSIS
od: R. V. Zeltchan, i wsp.
Wydane: (2018-05-01)

Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
od: O. E. Klementyeva, i wsp.
Wydane: (2024-07-01)

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions
od: Ajnas Alkatheeri, i wsp.
Wydane: (2025-02-01)

SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
od: G. E. Kodina, i wsp.
Wydane: (2019-01-01)

Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
od: O. E. Klementyeva, i wsp.
Wydane: (2021-12-01)

Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review)
od: E. P. Pavlenko, i wsp.
Wydane: (2023-12-01)

Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
od: A. S. Lunev, i wsp.
Wydane: (2024-02-01)

Peculiarities of the Regulatory Status of Radiopharmaceuticals Manufactured in Medical Organisations
od: S. V. Shatik, i wsp.
Wydane: (2022-12-01)

Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
od: Antonia Dimitrakopoulou-Strauss, i wsp.
Wydane: (2024-12-01)

Operational guidance on hospital radiopharmacy : a safe and effective approach [electronic resource] /
od: International Atomic Energy Agency
Wydane: (2008)

Operational guidance on hospital radiopharmacy : a safe and effective approach /
od: International Atomic Energy Agency
Wydane: (2008)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
od: Syeda Marab Saleem, i wsp.
Wydane: (2024-09-01)

Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats
od: Reza Bagheri, i wsp.
Wydane: (2024-12-01)

Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
od: A. O. Malysheva, i wsp.
Wydane: (2020-12-01)

Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
od: Fucen Liu, i wsp.
Wydane: (2025-03-01)

Can ChatGPT help patients understand radiopharmaceutical extravasations?
od: Madeleine Alvarez
Wydane: (2024-11-01)

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors
od: Alexis M. Sanwick, i wsp.
Wydane: (2024-12-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
od: Aryan Golzaryan, i wsp.
Wydane: (2025-02-01)

Results of individual dosimetric monitoring of the hands skin for personnel engaged in working with radiopharmaceuticals
od: E. N. Shleenkova, i wsp.
Wydane: (2025-01-01)

About the requirements of regular monitoring of doses for the eye lens of the staff working with radiopharmaceuticals
od: E. N. Shleenkova, i wsp.
Wydane: (2021-10-01)

An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography Applications
od: Reabetswe Sebatana, i wsp.
Wydane: (2025-02-01)

Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a <sup>177</sup>Lu radiopharmaceutical and local (intra-articular) therapy with a <sup>188</sup>Re radiopharmaceutical
od: E. D. Stepchenkova, i wsp.
Wydane: (2022-12-01)

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
od: Laura De Nardo, i wsp.
Wydane: (2024-11-01)